MONTREAL, June 15,
2022 /CNW Telbec/ - The Good Shroom Co Inc. (the
"Company" or "MUSH") (TSXV: MUSH), through its
licensed subsidiary Teonan Biomedical Inc., operates Nordique
Royale and Velada cannabis brands.
The Company is pleased to announce that it has expanded its
contract with the Government of Quebec which has accepted more cannabis
products to be sold in stores across the province beginning this
September. Additionally it has also increased its product offering
in Ontario beginning this
October.
In line with its continued mission of cannabis product
innovation the Company has doubled its current listing of products
in Quebec with
more traditional hash and hash infused products. The
Quebec cannabis market is the
largest in Canada estimated to be
over $650 million in sales.
Since the product launch in Quebec less than six months ago, 6 out of its
9 products have become top sellers in their categories according to
https://quebec.weedcrawler.ca/best_sellers. It also has a variety
of great reviews from key opinion leaders in Quebec's hash consumer community (See the
links below).
MUSH CEO Eric Ronsse stated:
"We've created a brand that resonates with a specific demographic
which creates loyalty to us and repeat business. The hash community
in particular loves our products. Our brands are beginning to have
recognition and that's what creates long term value."
Customer product reviews
-
https://www.reddit.com/r/sqdc/comments/s2dr11/le_afgan_gold_de_nordique_royale_distribu%C3%A9_par/
-
https://www.reddit.com/r/sqdc/comments/uo8an0/hash_afghan_gold_thc_28_cbd_10_nordique_royale/
-
https://www.reddit.com/r/sqdc/comments/stz01o/quelquun_a_essay%C3%A9_les_hash_%C3%A9quilibr%C3%A9_de_velada_ou/
-
https://www.reddit.com/r/sqdc/comments/s25k8l/hash_nordique_royale_le_choix_du_nord_276_thc_579/ht3gti0/?context=3
- https://www.instagram.com/p/Cd3Tq8QuE-N/
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Cautionary Note Regarding
Forward-Looking Information
This press release contains statements which constitute
"forward-looking statements" and "forward-looking information"
within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current
expectations of the Corporation with respect to future business
activities and sales, including the anticipated orders to be placed
by the SQDC. Forward-looking statements are often identified by the
words "may", "would", "could", "should", "will", "intend", "plan",
"anticipate", "believe", "estimate", "expect" or similar
expressions. Investors are cautioned that forward-looking
statements are not based on historical facts but instead reflect
the Corporation's expectations, estimates or projections concerning
future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the
statements are made. Although the Corporation believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed thereon, as unknown or
unpredictable factors could have material adverse effects on future
results, performance or achievements. Among the key factors that
could cause actual results to differ materially from those
projected are the following: market acceptance of the
Company's hash and other cannabis products, changes in the vendor's
business or strategy, changes in our supplier's operations and
pricing, expectations regarding competition and their pricing
strategy; maintaining in good standing all necessary regulatory
licenses and authorizations for its products; the benefits, safety,
efficacy, dosing and social acceptance of cannabis related products
and no material changes in the legal environment; changes in
applicable laws and regulations compliance with extensive
government regulation; operational risks related to and COVID-19 or
other pandemic and supply chain disruptions and shortages.
Should one or more of these risks or uncertainties materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or
expected. Although the Company has attempted to identify important
risks, uncertainties and factors which could cause actual results
to differ materially, there may be others that cause results not to
be as anticipated, estimated or intended and such changes could be
material. The Company does not intend, and do not assume any
obligation, to update the forward-looking statements except as
otherwise required by applicable law. Trading in the
securities of the Company should be considered highly
speculative.
SOURCE The Good Shroom Co Inc.